Ge‐Liang Xu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 5%
- Epidemiology
- Hepatology top 5%
- Co-authors
- Weidong JiaYongsheng GeJinliang MaJi-Hai YuWeihua RenJiansheng LiChuanhai ZhangWenbin Liu
- Topics
- Cancer, Hypoxia, and Metabolism (12 papers)Hepatocellular Carcinoma Treatment and Prognosis (11 papers)Peptidase Inhibition and Analysis (7 papers)
- Cited by
- HepatologyCancer ResearchOncology
In The Last Decade
Ge‐Liang Xu
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 661
- Oncology 359
- Cancer Research 354
- Epidemiology 216
- Hepatology 215
Countries citing papers authored by Ge‐Liang Xu
This map shows the geographic impact of Ge‐Liang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ge‐Liang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ge‐Liang Xu more than expected).
Fields of papers citing papers by Ge‐Liang Xu
This network shows the impact of papers produced by Ge‐Liang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ge‐Liang Xu. The network helps show where Ge‐Liang Xu may publish in the future.
Co-authorship network of co-authors of Ge‐Liang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ge‐Liang Xu. A scholar is included among the top collaborators of Ge‐Liang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ge‐Liang Xu. Ge‐Liang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 7 | |
| 3 | 18 | |
| 4 | 29 | |
| 5 | 2 | |
| 6 | 12 | |
| 7 | 0 | |
| 8 | 42 | |
| 9 | STRUCTURED TRIGLYCERIDES WERE WELL TOLERATED AND INDUCED AFTER HEPATECTOMY IN PATIENTS WITH HEPATOCARCINOMA | 1 |
| 10 | THE CLINICAL VALUE OF CONTRAST-ENHANCED ULTRASONOGRAPHY IN DIAGNOSING PRIMARY HEPATOCELLULAR CARCINOMA | 1 |
| 11 | 37 | |
| 12 | 9 | |
| 13 | 71 | |
| 14 | 45 | |
| 15 | 48 | |
| 16 | 33 | |
| 17 | 14 | |
| 18 | 22 | |
| 19 | 27 | |
| 20 | 49 |
About Ge‐Liang Xu
Ge‐Liang Xu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Hepatology (215 citations), Cancer Research (354 citations) and Oncology (359 citations). Ge‐Liang Xu has collaborated with scholars based in China and Egypt. Frequent co-authors include Weidong Jia, Yongsheng Ge, Jinliang Ma, Ji-Hai Yu, Weihua Ren, Jiansheng Li, Chuanhai Zhang, Wenbin Liu, Jiansheng Li and Xiaojie Sun. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.